Compressing settlement from two days to one didn't just cut compliance costs — it forced a permanent upgrade in collateral, funding, and securities-lending infrastructure that only a few banks were built to sell.
On May 28, 2024, the standard U.S. settlement cycle shrank from T+2 to T+1 — every stock and corporate bond trade now has to settle in one business day instead of two. The SEC sold it as counterparty-risk reduction: less time between trade and settlement means less exposure if someone defaults mid-transaction. That's true, and it's not the interesting part.
The interesting part is what T+1 does to the plumbing. Cutting the settlement window in half doesn't halve the work — it compresses trade affirmation, FX funding, securities lending recalls, and collateral movement into a window that increasingly can't tolerate manual processes or overnight batch cycles. Asset managers, hedge funds, and broker-dealers now need same-day funding certainty, real-time inventory visibility, and automated collateral optimization that didn't used to matter when everyone had 48 hours of slack. That need doesn't get built in-house by most buy-side firms. It gets bought — as a service — from whoever already runs the biggest, most automated prime brokerage and clearing books. Settlement risk was the headline. Balance-sheet-as-a-service is the business model that wins.
Settlement risk was the headline. Balance-sheet-as-a-service is the business model that wins.
Who cashes in:
- Goldman Sachs (GS) — Goldman's institutional prime brokerage franchise is one of the two or three largest in the world, and prime brokerage lives or dies on the ability to fund client positions and move collateral in real time. A tighter settlement cycle raises the value of a prime broker that can guarantee same-day funding, automated collateral substitution, and securities-lending recalls without manual intervention — precisely the sticky, high-margin service layer Goldman has spent years building around its Marquee platform.
- Morgan Stanley (MS) — Morgan Stanley's prime brokerage unit, inherited and scaled through its wealth-and-institutional buildout, sits alongside Goldman as the other dominant player in hedge fund financing. T+1 pushes hedge funds and asset managers to consolidate financing relationships with prime brokers who have already automated the funding and collateral chain, rewarding scale incumbents over smaller or slower competitors.
- JPMorgan (JPM) — As custodian, clearing bank, and one of the largest tri-party repo and collateral agents in the market, JPMorgan's securities services arm profits directly from higher demand for real-time collateral mobilization and intraday liquidity tools that T+1 makes non-optional rather than nice-to-have.
Who is exposed:
- Charles Schwab (SCHW) — Schwab's retail-custody-heavy model has less prime brokerage leverage to sell into this shift; the compliance burden (faster affirmation, tighter operational windows) is a cost center more than a revenue opportunity, since retail settlement was already largely automated and doesn't monetize collateral velocity the way institutional financing does.
- Citi (C) — Citi has a real markets and securities-services business, but it has spent years in restructuring mode with a smaller relative footprint in U.S. hedge fund prime brokerage than Goldman or Morgan Stanley, meaning it absorbs the same operational retooling costs without capturing an equivalent share of the financing-relationship consolidation.
The play: This isn't a one-quarter earnings story — it's a multi-year tailwind to the "financing" and "securities services" line items inside GS and MS results, and to JPM's markets/securities-services segment. Watch management commentary on prime brokerage balances and securities-lending revenue in quarterly filings, not the settlement-cycle headline itself. The SEC is also weighing a further push toward T+0 for some instruments — if that advances, the collateral-and-funding-tech premium these franchises capture only compounds.
Source: original report ↗
Free alerts Free: catalyst alerts, straight to your inbox.
Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $40/mo Join the owners who run ahead of the industry. Cancel anytime, one click.